Profile and Organization

Names, Facts, Figures about Bayer

Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.

Bayer group

An analysis by well-known branding agency Interbrand in 2015 valued the Bayer brand at €6.3 billion.

Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing mankind, and by doing this exceptionally well we aim to strengthen the company’s earning power.

We are committed to operating sustainably and to addressing our social and ethical responsibilities as a corporate citizen, while at the same time respecting the interests of all our stakeholders. Employees with a passion for innovation will enjoy excellent development opportunities at Bayer.

Bayer’s mission: Science For A Better Life

Focus on Life Science Businesses

Following the economic and legal separation of our MaterialScience business, now Covestro*, Bayer has charted the course for its successful development as a Life Science company. In this connection, we have realigned our corporate structure. Since January 1, 2016, Bayer’s core business has been managed by three divisions: Pharmaceuticals, Consumer Health and Crop Science. Animal Health is a separate reporting segment.

Our Life Science businesses hold leading positions in innovation-driven growth markets. Together they make up a strong, attractive and balanced portfolio that is resistant to fluctuations in demand and to potential risks. The previous structure comprising a strategic management holding company and operational subgroups has thus been replaced by an integrated organization under the umbrella of the strong Bayer brand.

Organization of Bayer

Business Operations Are the Responsibility of the Divisions

Bayer Divisions: Pharmaceuticals (prescription products)

The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the Radiology Business Unit which markets contrast-enhanced diagnostic imaging equipment together with the necessary contrast agents.

Bayer Divisions: Consumer Health (non-prescription products)

The Consumer Health Division markets mainly non-prescription products in the dermatology, dietary supplement, analgesic, gastrointestinal, allergy, cold and flu, foot care, sun protection and cardiovascular risk prevention categories. These products include globally known brands such as Claritin™, Aspirin™, Aleve™, Bepanthen™/Bepanthol™, Canesten™, Dr. Scholl’s™ and Coppertone™.

Bayer Divisions: Crop Science (Crop Protection)

The Crop Science Division has businesses in seeds, crop protection and non-agricultural pest control. It is organized into two operating units: Crop Protection/Seeds and Environmental Science. Crop Protection/Seeds markets a broad portfolio of high-value seeds along with innovative chemical and biological pest management solutions, at the same time providing extensive customer service for modern and sustainable agriculture. Environmental Science focuses on non-agricultural applications, with a broad portfolio of pest control products and services for areas ranging from the home and garden sector to forestry.

Bayer Divisions: Animal Health

The Animal Health Business Unit offers products and services for the prevention and treatment of diseases in companion and farm animals.

Central Service Functions

Bayer Service Functions: Bayer Business Services

The corporate functions and Business Services operate as Group-wide competence centers in which business support services are bundled.

Bayer Servicefunctions: Currenta

Currenta is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.

Covestro* is a leading supplier of high-tech polymer materials and develops innovative product solutions for a wide variety of everyday uses.

Corporate Governance

Dual governance system with the following governance bodies:

Board of Management:

eight members, Chairman: Dr. Marijn Dekkers1

Supervisory Board:

20 members, Chairman: Werner Wenning


until April 30, 2016; effective May 1, 2016, Werner Baumann


Bayer Products - medicine and agriculture

With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving peo­ple’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.

Best-selling Bayer products are:

  • in the health care field: Xarelto™, Kogenate™, Betaferon™/Betaseron™/Mirena product family , Nexavar™
  • the key brands in the agriculture field are: Confidor™ / Gaucho™, Nativo™ product family, Nunhems™, Basta™/ Liberty™, Prosaro™ product family


The Bayer Group comprises around 307 consolidated companies** in 77 countries throughout the world. Global headquarters are in Leverkusen, Germany.

** fully consolidated subsidiaries (as of Dec. 31, 2015)


On December 31, 2015, the Bayer Group had 116,800 employees worldwide. 

Bayer employees worldwide

Bayer Stock

Bayer Group Key Data

  2014 2015 Change
  € million € million %
Bayer Group      
Sales 41,339 46,324 +12.1
EBIT1 5,395 6,250 +15.8
EBIT before special items2 5,833 7,069 +21.2
EBITDA3 8,315 9,583 +15.2
EBITDA before special items2 8,685 10,266 +18.2
EBITDA margin before special items4 21.0% 22.2%  
Income before income taxes 4,414 5,245 +18.8
Net income 3,426 4,110 +20.0
Earnings per share (€)5 4.14 4.97 +20.0
Core earnings per share (€)6 5.89 6.83 +16.0
Gross cash flow7 6,707 6,999 +4.4
Net cash flow8 5,810 6,890 +18.6
Net financial debt 19,612 17,449 .
Capital expenditures as per segment table 2,484 2,556 +2.9
Research and development expenses 3,537 4,281 +21.0
Dividend per Bayer AG share (€) 2.25 2.50 +11.1

figures restated
1-8 for definition see footnotes to Bayer Group Key Data table

(as of Dec. 31, 2015)

Share of Sales by Segment 2015 

Bayer Share of Sales by Segment

(as of Dec. 31, 2015)

Since September 2015 Bayer MaterialScience is independent under the name Covestro*.


formerly Bayer MaterialScience more

Last updated: April 22, 2016 Copyright © Bayer AG